Crystallisation Process Development

As a world leader in pharmaceutical services, Almac delivers bespoke crystallisation development work programs for small molecules and peptides designed to provide a robust, scaleable, and transferrable crystallisation procedure to help accelerate clinical development and minimise risk in any downstream activities by eliminating batch-to-batch variability. The goals of typical studies include:

  • Impurity rejection / purge studies
  • Kinetics of nucleation and growth
  • Polymorphic form control
  • Maximising yield
  • Morphology engineering studies
  • Particle size control
  • Bulk density and powder flow improvement
  • Milling and micronisation studies
  • Isolation and drying processes
  • Control over residual solvent
  • Seeding protocol

Read the full article below to learn more.

View Resource

Download here instantly

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies